Daclatasvir (Daklinza) for Chronic Hepatitis C Cleared in EUDaclatasvir (Daklinza) for Chronic Hepatitis C Cleared in EU

The potent oral antiviral, indicated across multiple HCV genotypes and in combination with other oral drugs, yields cure rates of up to 100%, the manufacturer says. International Approvals
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Alert Source Type: news